MEI Pharma Inc

General ticker "MEIP" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $18.0M

MEI Pharma Inc does not follow the US Stock Market performance with the rate: -33.7%.

Estimated limits based on current volatility of 3.0%: low 2.38$, high 2.53$

Factors to consider:

  • Price in estimated range
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-06-30 to 2026-06-30

  • 2024-06-30 to 2025-06-30 estimated range: [1.83$, 4.68$]
  • 2025-06-30 to 2026-06-30 estimated range: [1.28$, 3.40$]

Financial Metrics affecting the MEIP estimates:

  • Positive: Non-GAAP EPS, $ of 4.30 > 2.29
  • Negative: Operating cash flow per share per price, % of -72.51 <= 2.35
  • Positive: Operating profit margin, % of 22.27 > 19.51
  • Negative: Industry operating cash flow per share per price (median), % of -23.08 <= 3.85
  • Negative: 0 < Inventory ratio change, % of 0.65

Similar symbols

Short-term MEIP quotes

Long-term MEIP plot with estimates

Financial data

YTD 2022-06-30 2023-06-30 2024-06-30
Operating Revenue $40.70MM $48.82MM $65.30MM
Operating Expenses $116.18MM $85.58MM $50.76MM
Operating Income $-75.48MM $-36.76MM $14.54MM
Non-Operating Income $21.03MM $4.93MM $3.24MM
Interest Expense $0.28MM $0.00MM $0.00MM
R&D Expense $85.64MM $52.45MM $16.56MM
Income(Loss) $-54.45MM $-31.84MM $17.78MM
Profit(Loss) $-54.45MM $-31.84MM $17.78MM
Stockholders Equity $52.41MM $24.62MM $33.02MM
Inventory $0.00MM $0.00MM $0.00MM
Assets $177.84MM $120.81MM $41.38MM
Operating Cash Flow $-48.75MM $-52.48MM $-50.47MM
Capital expenditure $0.48MM $0.04MM $0.01MM
Investing Cash Flow $6.89MM $53.69MM $49.14MM
Financing Cash Flow $49.05MM $-0.04MM $-11.87MM
Earnings Per Share* $-8.75 $-4.78 $2.67

* EPS are Split Adjusted, recent splits may be reflected with a delay.